View:
Download DOC
Download PDF
Download XLS
Download XBRL
abbv-20220930
0001551152falseDecember 312022Q3http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2022#InterestIncomeExpenseNonoperatingNet100015511522022-01-012022-09-300001551152exch:XCHIus-gaap:CommonStockMember2022-01-012022-09-300001551152us-gaap:CommonStockMemberexch:XNYS2022-01-012022-09-300001551152abbv:Sec1500SeniorNotesDue2023Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec1.375SeniorNotesDue2024Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec1250SeniorNotesDue2024Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec0.750SeniorNotesDue2027Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec2.125SeniorNotesdue2028Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec2625SeniorNotesDue2028Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec2125SeniorNotesDue2029Memberexch:XNYS2022-01-012022-09-300001551152abbv:Sec1.250SeniorNotesdue2031Memberexch:XNYS2022-01-012022-09-3000015511522022-10-26xbrli:shares00015511522022-07-012022-09-30iso4217:USD00015511522021-07-012021-09-3000015511522021-01-012021-09-30iso4217:USDxbrli:shares00015511522022-09-3000015511522021-12-310001551152us-gaap:CommonStockMember2021-06-300001551152us-gaap:TreasuryStockMember2021-06-300001551152us-gaap:AdditionalPaidInCapitalMember2021-06-300001551152us-gaap:RetainedEarningsMember2021-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001551152us-gaap:NoncontrollingInterestMember2021-06-3000015511522021-06-300001551152us-gaap:CommonStockMember2021-07-012021-09-300001551152us-gaap:TreasuryStockMember2021-07-012021-09-300001551152us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001551152us-gaap:RetainedEarningsMember2021-07-012021-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001551152us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:CommonStockMember2021-09-300001551152us-gaap:TreasuryStockMember2021-09-300001551152us-gaap:AdditionalPaidInCapitalMember2021-09-300001551152us-gaap:RetainedEarningsMember2021-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001551152us-gaap:NoncontrollingInterestMember2021-09-3000015511522021-09-300001551152us-gaap:CommonStockMember2022-06-300001551152us-gaap:TreasuryStockMember2022-06-300001551152us-gaap:AdditionalPaidInCapitalMember2022-06-300001551152us-gaap:RetainedEarningsMember2022-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001551152us-gaap:NoncontrollingInterestMember2022-06-3000015511522022-06-300001551152us-gaap:CommonStockMember2022-07-012022-09-300001551152us-gaap:TreasuryStockMember2022-07-012022-09-300001551152us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001551152us-gaap:RetainedEarningsMember2022-07-012022-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001551152us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:CommonStockMember2022-09-300001551152us-gaap:TreasuryStockMember2022-09-300001551152us-gaap:AdditionalPaidInCapitalMember2022-09-300001551152us-gaap:RetainedEarningsMember2022-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001551152us-gaap:NoncontrollingInterestMember2022-09-300001551152us-gaap:CommonStockMember2020-12-310001551152us-gaap:TreasuryStockMember2020-12-310001551152us-gaap:AdditionalPaidInCapitalMember2020-12-310001551152us-gaap:RetainedEarningsMember2020-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001551152us-gaap:NoncontrollingInterestMember2020-12-3100015511522020-12-310001551152us-gaap:CommonStockMember2021-01-012021-09-300001551152us-gaap:TreasuryStockMember2021-01-012021-09-300001551152us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300001551152us-gaap:RetainedEarningsMember2021-01-012021-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300001551152us-gaap:NoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:CommonStockMember2021-12-310001551152us-gaap:TreasuryStockMember2021-12-310001551152us-gaap:AdditionalPaidInCapitalMember2021-12-310001551152us-gaap:RetainedEarningsMember2021-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001551152us-gaap:NoncontrollingInterestMember2021-12-310001551152us-gaap:CommonStockMember2022-01-012022-09-300001551152us-gaap:TreasuryStockMember2022-01-012022-09-300001551152us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001551152us-gaap:RetainedEarningsMember2022-01-012022-09-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001551152us-gaap:NoncontrollingInterestMember2022-01-012022-09-300001551152abbv:SyndesiMemberus-gaap:CollaborativeArrangementMember2022-01-012022-03-310001551152abbv:SyndesiMembersrt:MaximumMemberus-gaap:CollaborativeArrangementMember2022-02-280001551152abbv:JuvisePharmaceuticalsMember2022-04-012022-06-300001551152abbv:JuvisePharmaceuticalsMemberus-gaap:OtherOperatingIncomeExpenseMember2022-04-012022-06-300001551152abbv:DJSAntibodiesLtdMembersrt:ScenarioForecastMemberus-gaap:SubsequentEventMember2022-10-012022-11-040001551152us-gaap:SubsequentEventMemberabbv:DJSAntibodiesLtdMembersrt:MaximumMember2022-11-040001551152abbv:CalicoLifeSciencesLLCMemberus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:TeneoOneMemberus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:TeneoOneMembersrt:MaximumMemberus-gaap:CollaborativeArrangementMember2021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2022-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2022-01-012022-09-30xbrli:pure0001551152abbv:JanssenBiotechIncMember2022-01-012022-09-300001551152abbv:JanssenBiotechIncMembercountry:USus-gaap:CollaborativeArrangementMember2022-07-012022-09-300001551152abbv:JanssenBiotechIncMembercountry:USus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:JanssenBiotechIncMembercountry:USus-gaap:CollaborativeArrangementMember2022-01-012022-09-300001551152abbv:JanssenBiotechIncMembercountry:USus-gaap:CollaborativeArrangementMember2021-01-012021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2022-07-012022-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2021-01-012021-09-300001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2021-12-310001551152abbv:GenentechInc.Member2022-01-012022-09-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2022-07-012022-09-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2022-01-012022-09-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-01-012021-09-300001551152abbv:GenentechInc.Membercountry:USus-gaap:CollaborativeArrangementMember2022-07-012022-09-300001551152abbv:GenentechInc.Membercountry:USus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:GenentechInc.Membercountry:USus-gaap:CollaborativeArrangementMember2022-01-012022-09-300001551152abbv:GenentechInc.Membercountry:USus-gaap:CollaborativeArrangementMember2021-01-012021-09-300001551152us-gaap:DevelopedTechnologyRightsMember2022-09-300001551152us-gaap:DevelopedTechnologyRightsMember2021-12-310001551152us-gaap:LicensingAgreementsMember2022-09-300001551152us-gaap:LicensingAgreementsMember2021-12-310001551152abbv:AllerganIntegrationPlanMember2022-09-300001551152abbv:AllerganIntegrationPlanMember2022-01-012022-09-300001551152us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-07-012022-09-300001551152us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-07-012021-09-300001551152us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-01-012022-09-300001551152us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-01-012021-09-300001551152us-gaap:CostOfSalesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300001551152us-gaap:CostOfSalesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-07-012021-09-300001551152us-gaap:CostOfSalesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-01-012022-09-300001551152us-gaap:CostOfSalesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-01-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-07-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-07-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-01-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-01-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-07-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-01-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-01-012021-09-300001551152us-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMember2022-07-012022-09-300001551152us-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMember2021-07-012021-09-300001551152us-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMember2022-01-012022-09-300001551152us-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMember2021-01-012021-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-07-012021-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-01-012022-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-01-012021-09-300001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-07-012022-09-300001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-07-012021-09-300001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-01-012022-09-300001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-01-012021-09-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-07-012021-09-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-01-012022-09-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-01-012021-09-300001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2021-12-310001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2021-12-310001551152us-gaap:EmployeeSeveranceMemberabbv:AllerganIntegrationPlanMember2022-09-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:OtherRestructuringMember2022-09-300001551152abbv:OtherRestructuringPlansMember2022-07-012022-09-300001551152abbv:OtherRestructuringPlansMember2022-01-012022-09-300001551152abbv:OtherRestructuringPlansMember2021-07-012021-09-300001551152abbv:OtherRestructuringPlansMember2021-01-012021-09-300001551152abbv:OtherRestructuringPlansMember2021-12-310001551152abbv:OtherRestructuringPlansMember2022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-12-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-01-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:TreasuryLockMember2019-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-09-30iso4217:EUR0001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-09-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-09-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-12-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMember2022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310001551152us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-09-300001551152us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMember2022-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-09-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:OtherLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-09-300001551152us-gaap:OtherLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-12-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-07-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-01-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001551152us-gaap:CostOfSalesMember2022-09-300001551152us-gaap:InterestExpenseMember2022-09-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-07-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-07-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-01-012021-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300001551152us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:TreasuryLockMember2022-07-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:TreasuryLockMember2021-07-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:TreasuryLockMember2022-01-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:TreasuryLockMember2021-01-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-01-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-07-012022-09-300001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-01-012022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-07-012022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2022-07-012022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2021-07-012021-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2022-01-012022-09-300001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2021-01-012021-09-300001551152us-gaap:FairValueMeasurementsRecurringMember2022-09-300001551152us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2022-09-300001551152us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001551152us-gaap:FairValueMeasurementsRecurringMember2021-12-310001551152us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2021-12-310001551152us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001551152srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2022-09-300001551152srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2022-09-300001551152srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2022-09-300001551152srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001551152srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001551152srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MinimumMember2022-09-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MaximumMember2022-09-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:WeightedAverageMember2022-09-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MinimumMember2021-12-310001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MaximumMember2021-12-310001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:WeightedAverageMember2021-12-310001551152srt:MinimumMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2022-09-300001551152abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMembersrt:MaximumMember2022-09-300001551152srt:WeightedAverageMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2022-09-300001551152srt:MinimumMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2021-12-310001551152abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMembersrt:MaximumMember2021-12-310001551152srt:WeightedAverageMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2021-12-310001551152abbv:ProjectedYearofPaymentsMembersrt:MinimumMember2022-09-300001551152abbv:ProjectedYearofPaymentsMembersrt:MaximumMember2022-09-300001551152srt:WeightedAverageMemberabbv:ProjectedYearofPaymentsMember2022-09-300001551152abbv:ProjectedYearofPaymentsMembersrt:MinimumMember2021-12-310001551152abbv:ProjectedYearofPaymentsMembersrt:MaximumMember2021-12-310001551152srt:WeightedAverageMemberabbv:ProjectedYearofPaymentsMember2021-12-310001551152srt:MinimumMemberabbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember2021-12-310001551152srt:MinimumMemberabbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember2022-09-300001551152abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMembersrt:MaximumMember2022-09-300001551152abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMembersrt:MaximumMember2021-12-310001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2022-09-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2022-09-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-09-300001551152us-gaap:FairValueInputsLevel1Member2022-09-300001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001551152us-gaap:FairValueInputsLevel1Member2021-12-310001551152us-gaap:AccountsReceivableMember2022-01-012022-09-30abbv:wholesaler0001551152us-gaap:AccountsReceivableMemberabbv:PrincipalUSCustomersMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-09-300001551152us-gaap:AccountsReceivableMemberabbv:PrincipalUSCustomersMemberus-gaap:GeographicConcentrationRiskMember2021-01-012021-12-310001551152abbv:HUMIRAMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300001551152abbv:HUMIRAMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-012021-09-300001551152abbv:SeniorNotesDue2022At3.450PercentMemberus-gaap:SeniorNotesMember2022-01-012022-01-310001551152abbv:SeniorNotesDue2022At3.450PercentMemberus-gaap:SeniorNotesMember2022-01-310001551152us-gaap:LoansPayableMemberabbv:FloatingRateTermLoanTrancheDueMay2025Member2022-02-280001551152us-gaap:LoansPayableMemberabbv:FloatingRateTermLoanTrancheDueMay2025Member2022-02-012022-02-280001551152us-gaap:LoansPayableMemberabbv:FloatingRateTermLoanTrancheDueMay2025RefinancedMember2022-02-280001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDue2022At3.250PercentMember2022-07-012022-07-310001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDue2022At3.250PercentMember2022-07-310001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDue2022At320PercentMember2022-09-012022-09-300001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDue2022At320PercentMember2022-09-300001551152abbv:SeniorNotes2.30PercentDue2021Memberus-gaap:SeniorNotesMember2021-04-012021-04-300001551152abbv:SeniorNotes2.30PercentDue2021Memberus-gaap:SeniorNotesMember2021-04-300001551152us-gaap:SeniorNotesMemberabbv:SeniorEuroNotesDue2021At0.500PercentMember2021-05-012021-05-310001551152us-gaap:SeniorNotesMemberabbv:SeniorEuroNotesDue2021At0.500PercentMember2021-05-310001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDueInMay2021AtFloatingRatesMember2021-05-012021-05-310001551152abbv:FloatingRateTermLoanTrancheDueMay2023Memberus-gaap:LoansPayableMember2021-09-300001551152abbv:FloatingRateTermLoanTrancheDueMay2023Memberus-gaap:LoansPayableMember2021-09-012021-09-300001551152abbv:FloatingRateTermLoanTrancheDueMay2023RefinancedMemberus-gaap:LoansPayableMember2021-09-300001551152abbv:SeniorNotesDue2021At5.000PercentMemberus-gaap:SeniorNotesMember2021-09-012021-09-300001551152abbv:SeniorNotesDue2021At5.000PercentMemberus-gaap:SeniorNotesMember2021-09-300001551152us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300001551152us-gaap:PensionPlansDefinedBenefitMember2021-07-012021-09-300001551152us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300001551152us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-09-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-07-012021-09-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-09-300001551152us-gaap:CostOfSalesMember2022-07-012022-09-300001551152us-gaap:CostOfSalesMember2021-07-012021-09-300001551152us-gaap:CostOfSalesMember2022-01-012022-09-300001551152us-gaap:CostOfSalesMember2021-01-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012021-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300001551152us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001551152us-gaap:EmployeeStockOptionMember2022-09-300001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2022-01-012022-09-300001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2022-09-300001551152us-gaap:SubsequentEventMember2022-10-282022-10-2800015511522021-10-292021-10-2900015511522022-09-092022-09-0900015511522021-09-102021-09-1000015511522022-06-232022-06-2300015511522021-06-172021-06-1700015511522022-02-172022-02-1700015511522021-02-182021-02-180001551152abbv:December2018StockRepurchaseAuthorizationMember2022-01-012022-09-300001551152abbv:December2018StockRepurchaseAuthorizationMember2021-01-012021-09-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2021-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-09-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2022-01-012022-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-09-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2022-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-09-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-09-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-09-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2020-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-09-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2021-01-012021-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-09-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2021-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-09-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-09-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2022-07-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2022-01-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2021-01-012021-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-07-012021-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-09-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-09-300001551152abbv:NiaspanMember2022-01-012022-09-30abbv:lawsuitabbv:class_actionabbv:direct_purchaserabbv:end_payor_purchaser0001551152abbv:AndroGelAntitrustLitigationKingDrugCoOfFlorenceIncEtAlVAbbVieIncEtAlMember2019-08-012019-08-31abbv:company0001551152abbv:HumiraAntitrustLitigationInReHumiraAdalimumabAntitrustLitigationMember2019-03-012019-05-310001551152abbv:BystolicAntitrustLitigationMember2022-01-012022-09-300001551152abbv:PrescriptionDrugAbuseLitigationMember2022-09-30abbv:claim0001551152abbv:PrescriptionDrugAbuseLitigationInStateCourtsMember2022-09-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMemberabbv:PrescriptionDrugAbuseLitigationInStateCourtsMember2022-09-300001551152abbv:ElliottAssociatesL.P.Member2016-06-012016-06-30abbv:investment_fund0001551152abbv:ElliottAssociatesL.P.Member2022-02-012022-02-280001551152abbv:ElliottAssociatesL.P.Member2022-01-012022-01-310001551152abbv:ImmunologyMemberabbv:HUMIRAMembercountry:US2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMembercountry:US2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMembercountry:US2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMembercountry:US2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:HUMIRAMember2021-01-012021-09-300001551152abbv:ImmunologyMembercountry:USabbv:SKYRIZIMember2022-07-012022-09-300001551152abbv:ImmunologyMembercountry:USabbv:SKYRIZIMember2021-07-012021-09-300001551152abbv:ImmunologyMembercountry:USabbv:SKYRIZIMember2022-01-012022-09-300001551152abbv:ImmunologyMembercountry:USabbv:SKYRIZIMember2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMembercountry:US2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMembercountry:US2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMembercountry:US2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMembercountry:US2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMember2022-07-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMember2021-07-012021-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMember2022-01-012022-09-300001551152abbv:ImmunologyMemberabbv:RINVOQMember2021-01-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMembercountry:US2022-07-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMembercountry:US2021-07-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMembercountry:US2022-01-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMembercountry:US2021-01-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMember2022-07-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMember2021-07-012021-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMember2022-01-012022-09-300001551152abbv:ImbruvicaMemberabbv:HematologicOncologyMember2021-01-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2022-07-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2021-07-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2022-01-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2021-01-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2022-07-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2021-07-012021-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2022-01-012022-09-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2021-01-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMembercountry:US2022-07-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMembercountry:US2021-07-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMembercountry:US2022-01-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMembercountry:US2021-01-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMember2022-07-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMember2021-07-012021-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMember2022-01-012022-09-300001551152abbv:BotoxCosmeticMemberabbv:AestheticsMember2021-01-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2022-07-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2021-07-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2022-01-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2021-01-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2022-07-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2021-07-012021-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2022-01-012022-09-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2021-01-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMembercountry:US2022-07-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMembercountry:US2021-07-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMembercountry:US2022-01-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMembercountry:US2021-01-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMember2022-07-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMember2021-07-012021-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMember2022-01-012022-09-300001551152abbv:OtherAestheticsMemberabbv:AestheticsMember2021-01-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMembercountry:US2022-07-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMembercountry:US2021-07-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMembercountry:US2022-01-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMembercountry:US2021-01-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2022-07-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2021-07-012021-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2022-01-012022-09-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2021-01-012021-09-300001551152abbv:VraylarMemberabbv:NeuroscienceMembercountry:US2022-07-012022-09-300001551152abbv:VraylarMemberabbv:NeuroscienceMembercountry:US2021-07-012021-09-300001551152abbv:VraylarMemberabbv:NeuroscienceMembercountry:US2022-01-012022-09-300001551152abbv:VraylarMemberabbv:NeuroscienceMembercountry:US2021-01-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMembercountry:US2022-07-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMembercountry:US2021-07-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMembercountry:US2022-01-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMembercountry:US2021-01-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2022-07-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2021-07-012021-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2022-01-012022-09-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2021-01-012021-09-300001551152abbv:UbrelvyMemberabbv:NeuroscienceMembercountry:US2022-07-012022-09-300001551152abbv:UbrelvyMemberabbv:NeuroscienceMembercountry:US2021-07-012021-09-300001551152abbv:UbrelvyMemberabbv:NeuroscienceMembercountry:US2022-01-012022-09-300001551152abbv:UbrelvyMemberabbv:NeuroscienceMembercountry:US2021-01-012021-09-300001551152abbv:NeuroscienceMembercountry:USabbv:QuliptaMember2022-07-012022-09-300001551152abbv:NeuroscienceMembercountry:USabbv:QuliptaMember2021-07-012021-09-300001551152abbv:NeuroscienceMembercountry:USabbv:QuliptaMember2022-01-012022-09-300001551152abbv:NeuroscienceMembercountry:USabbv:QuliptaMember2021-01-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMembercountry:US2022-07-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMembercountry:US2021-07-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMembercountry:US2022-01-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMembercountry:US2021-01-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2022-07-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2021-07-012021-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2022-01-012022-09-300001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2021-01-012021-09-300001551152abbv:EyeCareMembercountry:USabbv:LumiganGanfortMember2022-07-012022-09-300001551152abbv:EyeCareMembercountry:USabbv:LumiganGanfortMember2021-07-012021-09-300001551152abbv:EyeCareMembercountry:USabbv:LumiganGanfortMember2022-01-012022-09-300001551152abbv:EyeCareMembercountry:USabbv:LumiganGanfortMember2021-01-012021-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2022-07-012022-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2021-07-012021-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2022-01-012022-09-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2021-01-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMembercountry:US2022-07-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMembercountry:US2021-07-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMembercountry:US2022-01-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMembercountry:US2021-01-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2022-07-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2021-07-012021-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2022-01-012022-09-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2021-01-012021-09-300001551152abbv:EyeCareMembercountry:USabbv:RestasisMember2022-07-012022-09-300001551152abbv:EyeCareMembercountry:USabbv:RestasisMember2021-07-012021-09-300001551152abbv:EyeCareMembercountry:USabbv:RestasisMember2022-01-012022-09-300001551152abbv:EyeCareMembercountry:USabbv:RestasisMember2021-01-012021-09-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:RestasisMember2022-07-012022-09-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:RestasisMember2021-07-012021-09-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:RestasisMember2022-01-012022-09-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:RestasisMember2021-01-012021-09-300001551152abbv:EyeCareMemberabbv:RestasisMember2022-07-012022-09-300001551152abbv:EyeCareMemberabbv:RestasisMember2021-07-012021-09-300001551152abbv:EyeCareMemberabbv:RestasisMember2022-01-012022-09-300001551152abbv:EyeCareMemberabbv:RestasisMember2021-01-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMembercountry:US2022-07-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMembercountry:US2021-07-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMembercountry:US2022-01-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMembercountry:US2021-01-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMember2022-07-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMember2021-07-012021-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMember2022-01-012022-09-300001551152abbv:OtherEyeCareMemberabbv:EyeCareMember2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMembercountry:US2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMembercountry:US2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMembercountry:US2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMembercountry:US2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:CreonMembercountry:US2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:CreonMembercountry:US2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:CreonMembercountry:US2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:CreonMembercountry:US2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMembercountry:US2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMembercountry:US2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMembercountry:US2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMembercountry:US2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMemberus-gaap:NonUsMember2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMemberus-gaap:NonUsMember2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMemberus-gaap:NonUsMember2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMemberus-gaap:NonUsMember2021-01-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2022-07-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2021-07-012021-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2022-01-012022-09-300001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2021-01-012021-09-300001551152abbv:OtherProductsMember2022-07-012022-09-300001551152abbv:OtherProductsMember2021-07-012021-09-300001551152abbv:OtherProductsMember2022-01-012022-09-300001551152abbv:OtherProductsMember2021-01-012021-09-30abbv:segment

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                    to                                   
Commission File Number: 001-35565
https://cdn.kscope.io/e13ca0ec25d7c3a91e5b8a393617ced5-abbv-20220930_g1.jpg
AbbVie Inc.
(Exact name of registrant as specified in its charter)
Delaware
32-0375147
(State or other jurisdiction of incorporation or organization)
(I.R.S. employer identification number)
1 North Waukegan Road
North Chicago, Illinois 60064-6400
Telephone: (847) 932-7900
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.        Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
☒Accelerated Filer☐
Non-Accelerated Filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).        Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareABBVNew York Stock Exchange
Chicago Stock Exchange
1.500% Senior Notes due 2023ABBV23BNew York Stock Exchange
1.375% Senior Notes due 2024ABBV24New York Stock Exchange
1.250% Senior Notes due 2024ABBV24BNew York Stock Exchange
0.750% Senior Notes due 2027ABBV27New York Stock Exchange
2.125% Senior Notes due 2028ABBV28New York Stock Exchange
2.625% Senior Notes due 2028ABBV28BNew York Stock Exchange
2.125% Senior Notes due 2029ABBV29New York Stock Exchange
1.250% Senior Notes due 2031ABBV31New York Stock Exchange
As of October 26, 2022, AbbVie Inc. had 1,768,480,508 shares of common stock at $0.01 par value outstanding.


AbbVie Inc. and Subsidiaries
Table of Contents

Page



PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings (unaudited)

Three months ended
September 30,		Nine months ended
September 30,
(in millions, except per share data)2022202120222021
Net revenues$14,812 $14,342 $42,933 $41,311 
Cost of products sold5,022 4,390 13,244 13,126 
Selling, general and administrative3,304 3,083 11,843 9,089 
Research and development1,614 1,661 4,720 5,095 
Acquired IPR&D and milestones40 402 454 719 
Other operating expense, net229 500 57 432 
Total operating costs and expenses10,209 10,036 30,318 28,461 
Operating earnings4,603 4,306 12,615 12,850 
Interest expense, net497 585 1,568 1,813 
Net foreign exchange loss36 12 108 35 
Other expense (income), net(330)21 427 2,284 
Earnings before income tax expense4,400 3,688 10,512 8,718 
Income tax expense448 508 1,139 1,214 
Net earnings3,952 3,180 9,373 7,504 
Net earnings attributable to noncontrolling interest3 1 10 6 
Net earnings attributable to AbbVie Inc.$3,949 $3,179 $9,363 $7,498 
Per share data
Basic earnings per share attributable to AbbVie Inc.$2.22 $1.78 $5.26 $4.21 
Diluted earnings per share attributable to AbbVie Inc.$2.21 $1.78 $5.24 $4.19 
Weighted-average basic shares outstanding1,771 1,770 1,771 1,769 
Weighted-average diluted shares outstanding1,776 1,777 1,777 1,776 

The accompanying notes are an integral part of these condensed consolidated financial statements.
2022 Form 10-Q | https://cdn.kscope.io/e13ca0ec25d7c3a91e5b8a393617ced5-abbv-20220930_g2.gif
1

AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (unaudited)
Three months ended
September 30,		Nine months ended
September 30,
(in millions)2022202120222021
Net earnings$3,952 $3,180 $9,373 $7,504 
Foreign currency translation adjustments, net of tax expense (benefit) of $(11) for the three months and $(30) for the nine months ended September 30, 2022 and $(8) for the three months and $(32) for the nine months ended September 30, 2021
(989)(361)(2,043)(794)
Net investment hedging activities, net of tax expense (benefit) of $165 for the three months and $348 for the nine months ended September 30, 2022 and $51 for the three months and $123 for the nine months ended September 30, 2021
599 184 1,265 444 
Pension and post-employment benefits, net of tax expense (benefit) of $14 for the three months and $35 for the nine months ended September 30, 2022 and $17 for the three months and $50 for the nine months ended September 30, 2021
60 67 136 196 
Cash flow hedging activities, net of tax expense (benefit) of $14 for the three months and $17 for the nine months ended September 30, 2022 and $13 for the three months and $16 for the nine months ended September 30, 2021
83 57 98 115 
Other comprehensive loss(247)(53)(544)(39)
Comprehensive income3,705 3,127 8,829 7,465 
Comprehensive income attributable to noncontrolling interest3 1 10 6 
Comprehensive income attributable to AbbVie Inc.$3,702 $3,126 $8,819 $7,459 

The accompanying notes are an integral part of these condensed consolidated financial statements.




2022 Form 10-Q | https://cdn.kscope.io/e13ca0ec25d7c3a91e5b8a393617ced5-abbv-20220930_g2.gif
2

AbbVie Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in millions, except share data)September 30,
2022		December 31,
2021
(unaudited)
Assets
Current assets
Cash and equivalents$11,832 $9,746 
Short-term investments47 84 
Accounts receivable, net10,743 9,977 
Inventories3,172 3,128 
Prepaid expenses and other4,570 4,993 
Total current assets30,364 27,928 
Investments235 277 
Property and equipment, net4,893 5,110 
Intangible assets, net68,725 75,951 
Goodwill31,726 32,379 
Other assets5,382 4,884 
Total assets$141,325 $146,529 
Liabilities and Equity
Current liabilities
Short-term borrowings$10 $14 
Current portion of long-term debt and finance lease obligations9,197 12,481 
Accounts payable and accrued liabilities23,505 22,699 
Total current liabilities32,712 35,194 
Long-term debt and finance lease obligations60,399 64,189 
Deferred income taxes1,972 3,009 
Other long-term liabilities30,215 28,701 
Commitments and contingencies
Stockholders' equity
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,812,973,038 shares issued as of September 30, 2022 and 1,803,195,293 as of December 31, 2021
18 18 
Common stock held in treasury, at cost, 44,572,117 shares as of September 30, 2022 and 34,857,597 as of December 31, 2021
(4,590)(3,143)
Additional paid-in capital19,056 18,305 
Retained earnings4,953 3,127 
Accumulated other comprehensive loss(3,443)(2,899)
Total stockholders' equity15,994 15,408 
Noncontrolling interest33 28 
Total equity16,027 15,436 
Total liabilities and equity$141,325 $146,529 
The accompanying notes are an integral part of these condensed consolidated financial statements.
2022 Form 10-Q | https://cdn.kscope.io/e13ca0ec25d7c3a91e5b8a393617ced5-abbv-20220930_g2.gif
3

AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Equity (unaudited)

(in millions)Common shares outstandingCommon stockTreasury stockAdditional paid-in capitalRetained earningsAccumulated other comprehensive lossNoncontrolling interestTotal
Balance at June 30, 20211,767 $18 $(3,022)$17,936 $740 $(3,103)$25 $12,594 
Net earnings attributable to AbbVie Inc.— — — — 3,179 — — 3,179 
Other comprehensive loss, net of tax— — — — — (53)— (53)
Dividends declared— — — — (2,319)— — (2,319)
Purchases of treasury stock— — (6)— — — — (6)
Stock-based compensation plans and other1 — 8 172 — — — 180 
Change in noncontrolling interest— — — — — — 2 2 
Balance at September 30, 20211,768 $18 $(3,020)$18,108 $1,600 $(3,156)$27 $13,577 
Balance at June 30, 20221,768 $18 $(4,591)$18,906 $3,516 $(3,196)$35 $14,688 
Net earnings attributable to AbbVie Inc.— — — — 3,949 — — 3,949 
Other comprehensive loss, net of tax— — — — — (247)— (247)
Dividends declared— — — — (2,512)— — (2,512)
Purchases of treasury stock— — (4)— — — — (4)
Stock-based compensation plans and other— — 5 150 — — — 155 
Change in noncontrolling interest— — — — — — (2)(2)
Balance at September 30, 20221,768 $18 $(4,590)$19,056 $4,953 $(3,443)$33 $16,027 
Balance at December 31, 20201,765 $18 $(2,264)$17,384 $1,055 $(3,117)$21 $13,097 
Net earnings attributable to AbbVie Inc.— — — — 7,498 — — 7,498 
Other comprehensive loss, net of tax— — — — — (39)— (39)
Dividends declared— — — — (6,953)— — (6,953)
Purchases of treasury stock(7)— (803)— — — — (803)
Stock-based compensation plans and other10 — 47 724 — — — 771 
Change in noncontrolling interest— — — — — — 6 6 
Balance at September 30, 20211,768 $18 $(3,020)$18,108 $1,600 $(3,156)$27 $13,577 
Balance at December 31, 20211,768 $18 $(3,143)$18,305 $3,127 $(2,899)$28 $15,436 
Net earnings attributable to AbbVie Inc.— — — — 9,363 — — 9,363 
Other comprehensive loss, net of tax— — — — — (544)— (544)
Dividends declared— — — — (7,537)— — (7,537)
Purchases of treasury stock(10)— (1,483)— — — — (1,483)
Stock-based compensation plans and other10 — 36 751 — — — 787 
Change in noncontrolling interest— — — — — — 5 5 
Balance at September 30, 20221,768 $18 $(4,590)$19,056 $4,953 $(3,443)$33 $16,027 

The accompanying notes are an integral part of these condensed consolidated financial statements.
2022 Form 10-Q | https://cdn.kscope.io/e13ca0ec25d7c3a91e5b8a393617ced5-abbv-20220930_g2.gif
4

AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited)
Nine months ended
September 30,
(in millions) (brackets denote cash outflows)20222021
Cash flows from operating activities
Net earnings$9,373 $7,504 
Adjustments to reconcile net earnings to net cash from operating activities:
Depreciation582 630 
Amortization of intangible assets5,728 5,912 
Deferred income taxes(1,415)(153)
Change in fair value of contingent consideration liabilities647 2,447 
Stock-based compensation539 563 
Acquired IPR&D and milestones454